옵션 체인은 다양한 행사가격과 만기일에 대한 Artivion의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Artivion에 대한 시장 심리를 평가합니다..

Artivion (NYSE:AORT) 주식, 옵션 체인

ARTIVION INC

Artivion

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Artivion Inc

<a href="https://www.bloomberg.com/news/articles/2025-06-23/enbridge-enb-eyes-adding-pipeline-space-for-oil-flows-to-gulf-coast?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-23/enbridge-enb-eyes-adding-pipeline-space-for-oil-flows-to-gulf-coast?embedded-checkout=true</a>

News

General

'Enbridge Eyes Adding Pipeline Space for Oil Flows to Gulf Coast'- Bloomberg

<a href="https://www.bloomberg.com/news/articles/2025-06-23/iran-s-military-plans-proportionate-response-to-us-strikes?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-23/iran-s-military-plans-proportionate-response-to-us-strikes?embedded-checkout=true</a>

Politics

iShares MSCI Israel Capped Investable Market Index Fund

'Iran's Military Plans 'Proportionate' Response to US Strikes'- Bloomberg

Former Chrous One CIO Xavier Meegan launched Frachtis, a $20 million crypto-native pre-seed fund.
The fund is backed by investors including Theta Capital, RockawayX, Chorus One, and Cyber Fund.
Meegan led over 40 investments during his tenure at Chorus One. Now at Frachtis, his focus is on supporting technical crypto-native founders and supporting early-stage decentralized AI, infrastructure, middleware, and consumer applications.
&#8220;Frachtis was created to support technical founders who are deeply committed to building exceptional and innovative crypto products,&#8221; Meegan said.
Frachtis is structured as a solo general partner fund, supported by an advisory and investment committee. Brian Crain (Founder and CEO, Chorus One), Felix Lutsch (Head of Ecosystem, Symbiotic), Erwin Dassen (Head of Generative AI, Chorus One), and Mel Tsiaprazis (former COO, Bitstamp) are all on the committee.
Meegan believes the crypto market is entering a consumer applications era, where the next wave of winners will come from projects that build real-world applications on existing blockchain infrastructure. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46053180/sequans-takes-a-page-from-microstrategy-is-bitcoin-the-new-corporate-treasury-play">Sequans Takes A Page From MicroStrategy: Is Bitcoin The New Corporate Treasury Play?</a>
&#8220;Crypto-native products that solve real problems for users will become some of the most capital-efficient businesses in the world,&#8221; he said.
Frachtis has already invested in eight early-stage projects, including DeFi middleware project Turtle Club and decentralized AI infrastructure protocols Hyve and Bless. 
The fund's strategy focuses on crypto-native teams that leverage decentralized architecture from inception.
The fund's launch reflects growing investor interest in decentralized infrastructure, AI, and consumer-facing crypto applications, as venture capital continues to target the next stage of blockchain adoption.
Xavier Meegan brings both academic and practical expertise to the fund, having authored research papers on DeFi risk and contributed to blockchain research initiatives with Wharton and the World Economic Forum.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/m-a/25/06/46052819/anthony-pompliano-unveils-procap-financial-1b-bitcoin-treasury">Anthony Pompliano Unveils ProCap Financial With $1B Bitcoin Treasury After $750M Fundraise</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Entrepreneurship

Startups

Tech

New Crypto Fund Targets Early Builders: Is This Where The Next Blockchain Unicorn Starts?

WIIM

Impact BioMedical shares are trading higher after the company announced a limited merger and share exchange agreement with Dr Ashleys.

WBB Securities analyst Steve Brozak reiterates Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) with a Strong Buy and maintains $45 price target.

Price Target

Reiteration

Analyst Ratings

CDTX

WBB Securities Reiterates Strong Buy on Cidara Therapeutics, Maintains $45 Price Target

Stifel analyst Chris O'Cull maintains Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) with a Buy and raises the price target from $200 to $215.

Stifel Maintains Buy on Brinker International, Raises Price Target to $215

Needham analyst Joseph Stringer maintains Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) with a Buy and raises the price target from $36 to $54.

Needham Maintains Buy on Cidara Therapeutics, Raises Price Target to $54

The U.S. strike on Iran's nuclear facility on June 21 has raised the specter of a new oil crisis, reviving investor fears of energy-driven inflation and testing whether the stock market can <a href="https://www.benzinga.com/topic/iran">withstand another geopolitical shock.</a>
Historical precedent offers a guide to how the S&amp;P 500 index responds to energy-driven geopolitical upheaval—and the record shows that outcomes vary sharply depending on the broader economic context.
<h3 class="wp-block-heading">How Did The S&amp;P 500 React To Past Oil Crises?</h3>
In the first major oil shock in October 1973, triggered by the Arab oil embargo, the S&amp;P 500 – as tracked by the Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) – plunged 11.3% within a month and was down 41% one year later. 
The second oil shock in January 1978, tied to the start of the Iranian revolution, saw a more minor short-term hit—down 6.2% over a month—but the index recovered 5.3% over 12 months.
During the first Gulf War in August 1990, the S&amp;P 500 fell 9.4% in a month but rebounded 8.6% over the following year. In contrast, the 2003 Iraq invasion saw modest gains of 0.8% in one month and a strong 35% surge over 12 months.
The 2022 Russian invasion of Ukraine brought an initial 3.7% gain in the S&amp;P 500, but the index declined 12.4% a year later amid inflation and interest rate concerns.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Crisis Event</th>
<th>Start Date</th>
<th>1-Month S&amp;P 500 Return</th>
<th>12-Month S&amp;P 500 Return</th>
</tr>
</thead>
<tbody>
<tr>
<td>First Oil Shock (Arab oil embargo)</td>
<td>Oct 1973</td>
<td>-11.3%</td>
<td>-41.0%</td>
</tr>
<tr>
<td>Second Oil Shock (Iranian Revolution)</td>
<td>Jan 1978</td>
<td>-6.2%</td>
<td>+5.3%</td>
</tr>
<tr>
<td>First Gulf War</td>
<td>Aug 1990</td>
<td>-9.4%</td>
<td>+8.6%</td>
</tr>
<tr>
<td>Second Gulf War (Iraq Invasion)</td>
<td>Mar 2003</td>
<td>+0.8%</td>
<td>+35.0%</td>
</tr>
<tr>
<td>Russia-Ukraine War</td>
<td>Feb 2022</td>
<td>+3.7%</td>
<td>-12.4%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">The Real Market Damage May Come After The Oil Shock</h3>
While oil prices tend to surge during geopolitical shocks, history shows that the stock market pain often arrives later, when elevated energy costs start fueling inflation and central banks are forced to act by raising interest rates, thus reducing economic growth.
Prices peaked in January 1974 in the wake of the 1973 oil shock. The Federal Reserve raised interest rates in March of that year.
As borrowing costs rose, the S&amp;P 500 extended its decline, falling another 25% until it bottomed in October 1974. The oil shock initially triggered volatility, but the real equity damage came after monetary tightening.
A similar pattern followed the 1979 oil crisis. Oil peaked in May 1980, then fell 30% over the next three years. 
However, the S&amp;P 500 didn't bottom until July 1982, after falling 25% between November 1980 and mid-1982. This period coincided with Federal Reserve Chairman Paul Volcker raising interest rates to a record 20%, keeping them in double-digit territory until August 1982 to crush inflation.
The 2022 Russia-Ukraine war followed the same blueprint. Oil surged to $130 per barrel in March, then slid to $80 by October. The S&amp;P 500 suffered a 20% drawdown from March to October 2022 as the Federal Reserve began lifting interest rates, then accelerated the pace of hikes through the summer.
These episodes reveal a consistent pattern: initial oil shocks may trigger a knee-jerk reaction in markets, but the most damaging effects emerge as inflation lingers, central banks raise rates, and growth weakens.
Bottom line, oil spikes alone don't always sink equities.
But when prices stay high for months, the inflationary pressure builds, forcing central banks like the Federal Reserve to respond with tighter monetary policy.
That's when the real trouble begins.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46051051/oil-prices-iran-strait-of-hormuz-risk-us-attack">Oil At $110? Goldman Flags Major Risk If Iran Disrupts Strait Of Hormuz Shipping </a></li>
</ul>
Photo: Mohamad Reza Jamei/Shutterstock

Broad U.S. Equity ETFs

Global

Econ #s

Federal Reserve

ETFs

War, Oil, And S&P 500: Here's How The Stock Market Behaves In Energy Crises

Taylor Swift is the undisputed Queen of Pop, but she was recently bumped out of the top spot on a different list. Scale AI co-founder Lucy Guo has just replaced Swift as the world's youngest self-made female billionaire. According to<a href="https://www.forbes.com/sites/kerryadolan/2025/04/17/this-ai-founder-lucy-guo-scale-ai-has-unseated-taylor-swift-as-the-worlds-youngest-self-made-woman-billionaire/"> Forbes</a>, Guo is worth an astonishing $1.3 billion. Guo founded Scale AI with Alexandr Wang in 2016 when she was only 21. The company uses sophisticated data modeling to help develop AI applications.
Life is a question of timing, and Guo is reaping the rewards of building a successful<a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks"> AI company</a> when the sector is a magnet for investor capital. It should be noted, however, that she's not an overnight success story. She may be only 30, but Guo has spent more than half her life working with computers. According to the<a href="https://nypost.com/2025/06/04/business/ai-founder-lucy-guo-dethrones-taylor-swift-as-the-worlds-youngest-self-made-woman-billionaire/"> New York Post</a>, Guo first took up coding while attending middle school in the San Francisco Bay Area.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
She was an outstanding student who earned the right to attend Carnegie Mellon University. However, she dropped out after receiving a prestigious <a href="https://www.benzinga.com/markets/equities/25/06/45788736/peter-thiels-flying-car-dream-nears-reality-with-joby-aviation-but-joe-lonsdale-warns-faa-must-move-fast-as-china-could-overtake-us-amid-regulatory-delays">Thiel Fellowship</a> worth $100,000. The grant allowed her to solidify her tech credentials, first as an intern with Facebook, and then as Snapchat's first female designer. Guo moved on from Snapchat to take a position at Quora, where she met Wang.
The two co-founded Scale AI in 2016, but Wang was the CEO. The partnership soured due to philosophical differences and Wang would eventually fire Guo in 2018, but she didn't leave empty-handed.&nbsp; Guo retained a roughly 5% stake in Scale AI, which continued to build on its success in her absence. The company's client list includes the U.S. Department of Defense, Meta, and the Qatari government.
Guo, an admitted workaholic, is not short on personality and has a frugal streak that belies her net worth. "I don't like wasting money," Guo told<a href="https://fortune.com/2025/06/08/youngest-self-made-billionaire-on-the-planet-still-shops-at-shein-and-pulls-up-to-work-in-a-honda-civic-act-broke-stay-rich-lucy-guo-says/"> Fortune</a>. Although she admits to having a few fancy designer dresses in her closet, Guo notes they are the exception and not the rule. "Everything I wear is free or from Shein…Some of them aren't going to be that great quality, but there's always like two pieces or so that really work out, and I just wear them every day," she said.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
The Post also reports that Guo has a giant collection of Pokémon memorabilia that includes everything from slippers to stuffed animals. She also enjoys skateboarding. It might seem a little pedestrian, but that fits into Guo's penchant for understated living. She loves a good time but doesn't spend lavishly. Nor does she feel the need to flaunt her wealth.
"Who you see typically wasting money on designer clothes, a nice car, et cetera, they're technically in the millionaire range," Guo told Fortune. "All their friends are multimillionaires or billionaires, and they feel a little bit insecure, so they feel the need to be flashy to show other people, ‘Look, I'm successful.' I'm not showing off to anyone, right?"
Despite her $1 billion-plus fortune, Guo is not resting on her laurels. She also runs a company called Passes, which bills itself as a PG-rated version of OnlyFans. That's in addition to her time running Backend Capital, an investment firm that raises seed money for startups.&nbsp; All things considered, Guo has already enjoyed a full career, but if her past success is any indication, she has only just begun.
Read Next:
<ul class="wp-block-list">
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

A New Queen Of Green--Hard-Charging Tech Mogul Replaces Taylor Swift As The World's Youngest Self-Made Woman Billionaire

RBC Capital analyst Maurice Choy maintains Keyera (TSX:<a class="ticker" href="https://www.benzinga.com/stock/KEY#TSX">KEY</a>) with a Outperform and raises the price target from C$46 to C$53.

TSX:KEY

RBC Capital Maintains Outperform on Keyera, Raises Price Target to C$53

<a href="https://www.bloomberg.com/news/articles/2025-06-23/wolfspeed-plans-bankruptcy-after-clinching-deal-with-creditors">https://www.bloomberg.com/news/articles/2025-06-23/wolfspeed-plans-bankruptcy-after-clinching-deal-with-creditors</a>

WOLF

'Wolfspeed Plans Bankruptcy After Clinching Deal With Creditors'- Bloomberg

Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has outperformed the market over the past 5 years by 15.67% on an annualized basis producing an average annual return of 30.41%. Currently, Oracle has a market capitalization of $573.96 billion. 
Buying $100 In ORCL: If an investor had bought $100 of ORCL stock 5 years ago, it would be worth $374.73 today based on a price of $204.34 for ORCL at the time of writing.
<h3>Oracle's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750691732_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ORCL

Here's How Much $100 Invested In Oracle 5 Years Ago Would Be Worth Today

RBC Capital analyst Josh Wolfson reiterates Agnico Eagle Mines (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AEM#TSX">AEM</a>) with a Outperform and maintains C$145 price target.

TSX:AEM

RBC Capital Reiterates Outperform on Agnico Eagle Mines, Maintains C$145 Price Target

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) with a Outperform and raises the price target from $376 to $404.

RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $404

Oil is trading lower amid hopes that Iran does not retaliate against the United States after it joined Israel in striking the country's main nuclear facilities. US Secretary of State Rubio urged China to help prevent Iran from closing the Strait of Hormuz as tankers slow navigation in the waterway. President Trump on Truth Social addressed the US Department of Energy and said "DRILL, BABY, DRILL!!! And I mean NOW!!!"

RBC Capital analyst Rishi Jaluria reiterates Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) with a Outperform and maintains $290 price target.

GWRE

RBC Capital Reiterates Outperform on Guidewire Software, Maintains $290 Price Target

DA Davidson analyst Michael Shlisky maintains Wabash National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNC#NYSE">WNC</a>) with a Neutral and raises the price target from $7.5 to $9.5.

DA Davidson Maintains Neutral on Wabash National, Raises Price Target to $9.5

RBC Capital analyst Brad Erickson reiterates GoDaddy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) with a Outperform and maintains $225 price target.

GDDY

RBC Capital Reiterates Outperform on GoDaddy, Maintains $225 Price Target

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Monday.
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose sharply during Monday's session amid the Robotaxi <a href="https://www.benzinga.com/markets/tech/25/06/46051889/teslas-4-20-robotaxi-disruption-waymo-should-be-worried">launch in Austin, TX</a>.
Tesla has officially rolled out its much-awaited Robotaxi in Austin, Texas, with a limited number of Model Y Robotaxis in the South Congress neighborhood.
&#8220;Our approach to autonomy also enables scalability: Tesla self-driving can be deployed anywhere it's approved,&#8221; the company said in a post on social media platform X on Sunday after the Robotaxi launch.
Tesla shares jumped 9.3% to $352.11 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>SpartanNash Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPTN#NASDAQ">SPTN</a>) shares jumped 49.5% to $26.36 after the company announced it will be acquired by C&amp;S Wholesale Grocers.</li>
<li>Standard BioTools Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NASDAQ">LAB</a>) gained 36.3% to $1.43 after the company announced a strategic sale of SomaLogic to Illumina.</li>
<li>CorMedix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) rose 25.6% to $17.10 after the company raised its second-quarter net sales guidance.</li>
<li>Zeta Global Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NASDAQ">ZETA</a>) gained 20.2% to $17.05.</li>
<li>AIRO Group Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRO#NASDAQ">AIRO</a>) rose 19% to $26.47.</li>
<li>Epsium Enterprise Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPSM#NASDAQ">EPSM</a>) gained 16.5% to $26.62.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) rose 14.8% to $275.90 after the company announced a partnership with Fiserv to use its stablecoin platform with Fiserv&#8217;s digital banking and payment capabilities.</li>
<li>Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) gained 13% to $2.9479 after announcing positive six-month clinical results from Type 1 diabetes study of Islet Cell Transplantation without Immunosuppression.</li>
<li>Ouster, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NASDAQ">OUST</a>) rose 11.8% to $24.11.</li>
<li>Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) gained 10% to $44.39 after the company topline results from the STELLAR-303 phase 3 pivotal trial. Also, JMP Securities raised its price target on the stock from $47 to $50.</li>
<li>Scholastic Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCHL#NASDAQ">SCHL</a>) rose 9.4% to $20.92 as the company issued update on strategic and operational initiatives.</li>
<li>Northern Trust Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) gained 8.5% to $121.44 following a report suggesting the Bank of New York Mellon approached the company to discuss a potential merger.</li>
<li>IAMGOLD Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAG#NYSE">IAG</a>) gained 8% to $7.83 as the company said Côté Gold Mine reached major milestone as processing plant operated at nameplate capacity of 36,000 tpd on average over thirty consecutive days.</li>
<li>Manchester United plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) climbed 5.8% to $18.38.</li>
<li>FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) rose 4.7% to $442.01 following upbeat quarterly sales.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46023851/top-2-tech-stocks-that-could-sink-your-portfolio-in-june">Top 2 Tech Stocks That Could Sink Your Portfolio In June</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Movers

AIRO

CRCL

CRMD

EPSM

EXEL

MANU

NTRS

OUST

SANA

SCHL

SPTN

TSLA

ZETA

Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday

D. Boral Capital analyst Jason Kolbert upgrades CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) from Hold to Buy and announces $30 price target.

Upgrades

CERO

D. Boral Capital Upgrades CERo Therapeutics Hldgs to Buy, Announces $30 Price Target

Press Releases

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

Earnings

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

Comments

Artivion

Artivion (AORT) 옵션

Artivion (NYSE:AORT) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌